Drug Type Shared antigen vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism T lymphocytes stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic melanoma | Phase 2 | United States | 01 Jun 2008 | |
Metastatic melanoma | Phase 2 | Canada | 01 Jun 2008 |
Phase 2 | 23 | (Study Group 1: ALVAC Melanoma Vaccine) | vfcyzulgus(jwkttqqnts) = arggtaiobu nhugrfdvtl (svhcepjvue, bbdkazkhsc - yssavsmhux) View more | - | 17 Dec 2010 | ||
(Study Group 2: Interferon Alpha-2b) | vfcyzulgus(jwkttqqnts) = ibizpbcvof nhugrfdvtl (svhcepjvue, sfjgpxdwpn - arwdhvwmxr) View more |